Kết quả tìm kiếm - Jonathan Reuning‐Scherer
- Đang hiển thị 1 - 2 kết quả của 2
-
1
Effect of radium-223 dichloride (Ra-223) on hospitalisation: An analysis from the phase 3 randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) trial Bằng Christopher Parker, Lin Zhan, Paul Cislo, Jonathan Reuning‐Scherer, Nicholas J. Vogelzang, Sten Nilsson, Oliver Sartor, Joe M. O’Sullivan, Robert E. Coleman
Được phát hành 2016Artigo -
2
Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA study Bằng Sten Nilsson, Paul Cislo, Oliver Sartor, Nicholas J. Vogelzang, Robert E. Coleman, Joe M. O’Sullivan, Jonathan Reuning‐Scherer, Minghua Shan, Zhan Lu, Chris Parker
Được phát hành 2016Artigo